Acadian Asset Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.86M | Buy |
2,424,363
+91,118
| +4% | +$333K | 0.02% | 455 |
|
|
2025
Q1 | $10.1M | Sell |
2,333,245
-751,458
| -24% | -$3.24M | 0.03% | 332 |
|
|
2024
Q4 | $9.87M | Buy |
3,084,703
+65,655
| +2% | +$210K | 0.03% | 363 |
|
|
2024
Q3 | $8.63M | Sell |
3,019,048
-55,327
| -2% | -$158K | 0.03% | 372 |
|
|
2024
Q2 | $8.61M | Buy |
3,074,375
+72,696
| +2% | +$203K | 0.03% | 381 |
|
|
2024
Q1 | $8.52M | Buy |
3,001,679
+471,741
| +19% | +$1.34M | 0.03% | 343 |
|
|
2023
Q4 | $10.3M | Sell |
2,529,938
-60,306
| -2% | -$247K | 0.04% | 283 |
|
|
2023
Q3 | $8.23M | Buy |
2,590,244
+548,175
| +27% | +$1.74M | 0.03% | 324 |
|
|
2023
Q2 | $6.78M | Buy |
2,042,069
+633,356
| +45% | +$2.1M | 0.03% | 377 |
|
|
2023
Q1 | $3M | Buy |
1,408,713
+219,098
| +18% | +$466K | 0.01% | 604 |
|
|
2022
Q4 | $3.2M | Buy |
1,189,615
+382,817
| +47% | +$1.03M | 0.02% | 557 |
|
|
2022
Q3 | $2.61M | Buy |
+806,798
| New | +$2.61M | 0.01% | 556 |
|
|
2022
Q1 | – | Sell |
-2,600
| Closed | -$24K | – | 1751 |
|
|
2021
Q4 | $24K | Sell |
2,600
-195,276
| -99% | -$1.8M | ﹤0.01% | 1588 |
|
|
2021
Q3 | $2.82M | Buy |
197,876
+65,443
| +49% | +$931K | 0.01% | 596 |
|
|
2021
Q2 | $2.2M | Buy |
132,433
+97,891
| +283% | +$1.63M | 0.01% | 690 |
|
|
2021
Q1 | $630K | Buy |
+34,542
| New | +$630K | ﹤0.01% | 1115 |
|